Patents by Inventor Ferda Yantiri-Wernimont

Ferda Yantiri-Wernimont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150118689
    Abstract: A system comprised of a device for measuring hemoglobin content and/or determining a hematocrit value and/or measuring a hematocrit value, and a device for measuring or detecting an analyte, and a method for measuring or determining the presence of at least one analyte are described.
    Type: Application
    Filed: October 23, 2014
    Publication date: April 30, 2015
    Inventors: Richard L. Egan, Larry Thomas Mimms, Ferda Yantiri-Wernimont
  • Publication number: 20080287309
    Abstract: This disclosure relates to methods for selecting antibodies having desirable characteristics from a population of diverse antibodies. More specifically, this disclosure provides methods for identifying antibodies which bind to cancer cells, but which do not bind to human red blood cells, white blood cells or normal tissue cells. Antibodies of the disclosure can be used for therapeutic and/or diagnostic purposes.
    Type: Application
    Filed: July 8, 2005
    Publication date: November 20, 2008
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Katherine S. Bowdish, Hong Xin, Ferda Yantiri-Wernimont, Amara Siva
  • Publication number: 20080008719
    Abstract: The present application relates to methods and compositions for the treatment of cancer. In specific embodiments, the application relates to the use of antibodies capable of modulating CDCP1 as therapeutic agents for the treatment of cancer and as diagnostic agents for the detection of and/or prognosis of cancer.
    Type: Application
    Filed: April 24, 2007
    Publication date: January 10, 2008
    Inventors: Katherine Bowdish, Hong Xin, Ferda Yantiri-Wernimont, Amara Siva